Cargando…

Managing Prolactinomas during Pregnancy

Prolactinomas are the most prevalent functional benign pituitary tumors due to a pituitary micro- or macroadenoma. The majority of patients presents with infertility and gonadal dysfunction. A dopamine agonist (DA) (bromocriptine or cabergoline) is the treatment of choice that can normalize prolacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almalki, Mussa Hussain, Alzahrani, Saad, Alshahrani, Fahad, Alsherbeni, Safia, Almoharib, Ohoud, Aljohani, Naji, Almagamsi, Abdurahman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443771/ https://www.ncbi.nlm.nih.gov/pubmed/26074878 http://dx.doi.org/10.3389/fendo.2015.00085

Ejemplares similares

Clinical Features, Therapeutic Trends, and Outcome of Giant Prolactinomas: A Single-Center Experience Over a 12-Year Period
por: Almalki, Mussa H, et al.
Publicado: (2020)

Glycemic control and pregnancy outcomes in patients with diabetes in pregnancy: A retrospective study
por: Buhary, Badurudeen Mahmood, et al.
Publicado: (2016)

Options for Controlling Type 2 Diabetes during Ramadan
por: Almalki, Mussa H., et al.
Publicado: (2016)

Effect of Tamoxifen on the Management of Dopamine Agonist-Resistant Prolactinomas: A Systematic Review
por: Bazuhair, Tuqa, et al.
Publicado: (2023)

Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
por: Almistehi, Wael M, et al.
Publicado: (2018)

Vitamin D: Light side and best time of sunshine in Riyadh, Saudi Arabia
por: Alshahrani, Fahad M., et al.
Publicado: (2013)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Prolactinoma: Clinical Characteristics, Management and Outcome
por: Irfan, Hira, et al.
Publicado: (2022)

Obstructive Hydrocephalus, Fifth Nerve and Hypothalamus Involvement: Acute Presentation of a Giant Prolactinoma
por: Alkatari, Shadin, et al.
Publicado: (2012)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022)

Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery
por: Zielinski, Grzegorz, et al.
Publicado: (2020)

Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas
por: Huber, Markus, et al.
Publicado: (2022)

Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
por: Cho, Anna, et al.
Publicado: (2022)

Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?
por: Ferraris, Jimena
Publicado: (2023)

Italian Guidelines for the Management of Prolactinomas
por: Cozzi, Renato, et al.
Publicado: (2023)

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists
por: Tang, Hao, et al.
Publicado: (2021)

Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery”
por: Andereggen, Lukas, et al.
Publicado: (2021)

Vitamin D: Deficiency, Sufficiency and Toxicity
por: Alshahrani, Fahad, et al.
Publicado: (2013)

Primary Hypothyroidism with Markedly High Prolactin
por: Ansari, Mohd Saleem, et al.
Publicado: (2016)

Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases
por: Gonzaga, Maria de Fátima de Magalhães, et al.
Publicado: (2018)

Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas
por: Medina, Eduardo J., et al.
Publicado: (2023)

Association of Glycosylated Hemoglobin Levels With Vitamin D Status
por: Buhary, Badurudeen Mahmood, et al.
Publicado: (2017)

Intrathyroidal Parathyroid Cyst: An Unusual Neck Mass
por: Ahmad, Maswood M, et al.
Publicado: (2017)

Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?
por: Vilar, Lucio, et al.
Publicado: (2015)

Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center
por: Yang, Aram, et al.
Publicado: (2020)

Case Report: Multiple prolactinomas in a young man with Kallmann syndrome and familial hypocalciuric hypercalcemia
por: Jensterle, Mojca, et al.
Publicado: (2023)

Undiagnosed hypoglycaemia disorders in children detected when hypoglycaemia occurs in the setting of illness: a retrospective study
por: Rosenfeld, Elizabeth, et al.
Publicado: (2023)

Gender Disparities in Prolactinomas: Unravelling Clinical Patterns, Metabolic Variations, and Treatment Responses
por: Baba, Mohammad Salem, et al.
Publicado: (2023)

Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1
por: Dantas, Naiara C. B., et al.
Publicado: (2019)

Assessment of Ramadan Education and Knowledge Among Diabetic Patients
por: Almalki, Mussa Hussain, et al.
Publicado: (2018)

Pediatric Giant Prolactinoma Presenting With Acute Obstructive Hydrocephalus and Intracranial Hypertension
por: Hendrix, Grace, et al.
Publicado: (2021)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy
por: Bajwa, Sukhwinder Kaur, et al.
Publicado: (2011)

Malignant Prolactinoma With Liver Metastases Masquerading as Metastatic Gastrointestinal Stromal Tumor: A Case Report and Literature Review
por: Hong, A Ram, et al.
Publicado: (2020)

Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
por: Bima, Chiara, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

SAT378 Unusual Case of Hirsutism From Prolactinoma Induced Dihydrotestosterone Elevation
por: Ambalavanan, Jayachidambaram, et al.
Publicado: (2023)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) gene
por: Vroonen, Laurent, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_97d2btavk7qrmu3s5i91hntnuu